Thus, we speculate that the increased expression of IL-33 in tumor cells may contribute to abnormal DDR through transcriptional regulation of HR genes and IL-33/ST2/MAPK-mediated NHEJ activation. This evidence concerns the gene IL33 and neoplasm.